88 -4 (54) 2023 — Isakova Dilnoza Bakhtiyarovna — INNOVATIVE METHODS OF EARLY DIAGNOSTICS AND NEW SCREENING TECHNOLOGIES FOR DISEASES OF THE CERVICAL UTTERIOUS

INNOVATIVE METHODS OF EARLY DIAGNOSTICS AND NEW SCREENING TECHNOLOGIES FOR DISEASES OF THE CERVICAL UTTERIOUS

Isakova Dilnoza Bakhtiyarovna  Andijan State Medical Institute

Resume

Cervical cancer is one of the few cancers that can be prevented. When it is diagnosed at an early stage, the disease is more amenable to effective treatment, which increases overall and disease-free survival, improves the quality of life of patients, and reduces the cost of treatment.

Keywords: cervical disease, HPV oncogenic types, screening technologies

First page

480

Last page

482

For citation: Isakova Dilnoza Bakhtiyarovna – INNOVATIVE METHODS OF EARLY DIAGNOSTICS AND NEW SCREENING TECHNOLOGIES FOR DISEASES OF THE CERVICAL UTTERIOUS //New Day in Medicine 4(54)2023 480-482 https://newdaymedicine.com/index.php/2023/04/25/f/

LIST OF REFERENCES:

1. Сухих Г.Т., Прилепская В.Н., Профилактика рака шейки матки: / Руководство для врачей. 3-е изд. М.: МЕДпресс-информ; 2012;192.
2. Роговская С.И. Папилломавирусная инфекция у женщин и патология шейки матки: в помощь практикующему врачу. / 2-е изд. М.: ГЭОТАР-Медиа; 2018;192.
3. Muñoz N., Bosch F.X., Castellsagué X., Díaz M., de Sanjose S., Hammouda D. et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. // Int. J. Cancer. 2014;111(2):278–85.
4. Snijders P., van den Brule A., Meijer C. The clinical relevance of human papillomavirus testing: relationship between analytical and clinical sensitivity. // J. Pathol. 2013;201(1):1-5.
5. Bleotu C., Botezatu A., Goia C.D., Socolov D., Corniţescu F., Teleman S. et al.P16ink4A-A possible marker in HPV persistence screening. // Roum. Arch. Microbiol. Immunol. 2019; 68(3):183–9.
6. Стерн П.Л., Г.С.Китченер Г.С., ред. Вакцина для профилактики рака шейки матки: Пер. с англ. Сухих Г.Т., Прилепская В.Н., ред. / М.: МЕДпресс-информ; 2009;192.
7. Davey E., Barratt A., Irwig L., Chan S.F., Macaskill P., Mannes P., Saville A.M. Effect of study design and quality on unsatisfactory rates, cytology classifications, and accuracy in liquid-based versus conventional cervical cytology: a systematic review. Lancet. 2016; 376(9505):122–32.
8. Franco E.L., Harper D.M. Vaccination against human papillomavirus infection: a new paradigm in cervical cancer control. // Vaccine. 2015;23(17-18):2388-94.
9. Nuovo J., Melnikow J., Howell L.P. New tests for cervical cancer screening. // Am. Fam. Physician. 2011;64:L780-6.
10.  Pierry D., Weiss G., Lack B., Chen V., Fusco J. Intracellular human papillomavirus E6, E7 mRNA quantification predicts CIN 2+ in cervical biopsies better than Papanicolaou screening for women regardless of age. // Arch. Pathol. Lab. Med. 2012;136(8):956-60.